SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-023114
Filing Date
2023-08-10
Accepted
2023-08-10 16:49:22
Documents
23
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vtgn20230810_8k.htm   iXBRL 8-K 23438
2 EXHIBIT 99.1 ex_558852.htm EX-99.1 119710
7 slide1.jpg GRAPHIC 99644
8 slide2.jpg GRAPHIC 103829
9 slide3.jpg GRAPHIC 53484
10 slide4.jpg GRAPHIC 64581
11 slide5.jpg GRAPHIC 66376
12 slide6.jpg GRAPHIC 56161
13 slide7.jpg GRAPHIC 74435
14 slide8.jpg GRAPHIC 89086
15 vtgn01.jpg GRAPHIC 3245
  Complete submission text file 0001437749-23-023114.txt   1132190

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20230810.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20230810_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20230810_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20230810_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT vtgn20230810_8k_htm.xml XML 2563
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 231160350
SIC: 2834 Pharmaceutical Preparations